Press Releases October 1, 2026 04:30 PM

Alerus Financial Corporation to Announce Third Quarter Financial Results on Wednesday, October 28

Alerus Financial Corporation Schedules Third Quarter 2026 Financial Results Release and Conference Call

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
ALRS

Alerus Financial Corporation announced the release date for its third quarter financial results on October 28, 2026, followed by a conference call on October 29 to discuss the outcomes with analysts and institutional investors. The company operates as a commercial wealth bank and national retirement services provider with multiple office locations across the US.

Alerus Financial Corporation to Announce Third Quarter Financial Results on Wednesday, October 28
ALRS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Alerus Financial Corporation will release Q3 2026 financial results on October 28, 2026.
  • A conference call for discussing financial results will be held on October 29, 2026, including a Q&A session.
  • The company offers diverse financial solutions including banking, wealth services, and retirement benefits with offices primarily in the Midwest and Southwest US.
  • The announcement pertains to the financial services and banking sectors, impacting investors and stakeholders interested in regional commercial banking and retirement service industries.

MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Alerus Financial Corporation (Nasdaq: ALRS) announced that it will issue its third quarter financial results on Wednesday, October 28, 2026.

Alerus Financial Corporation will also host a conference call at 11:00 a.m. Central Time on Thursday, October 29, 2026, to discuss its financial results. Analysts and institutional investors may participate in the question-and-answer session. Attendees are encouraged to register ahead of time for the call.

Conference Call Information
Date: Thursday, October 29, 2026
Time: 12:00 p.m. Eastern Time / 11:00 a.m. Central Time
Register: https://register-conf.media-server.com/register/BId3e273182c914c8a81b55efe60756bf7

A recording of the call and transcript will be available at investors.alerus.com following the call.

About Alerus Financial Corporation
Alerus Financial Corporation (Nasdaq: ALRS) is a commercial wealth bank and national retirement services provider with corporate offices in Grand Forks, North Dakota, and the Minneapolis-St. Paul, Minnesota metropolitan area. Through its subsidiary, Alerus Financial, National Association, Alerus provides diversified and comprehensive financial solutions to business and consumer clients, including banking, wealth services, and retirement and benefit plans and services. Alerus provides clients with a primary point of contact to help fully understand their unique needs and delivery channel preferences. Clients are provided with competitive products, valuable insight, and sound advice supported by digital solutions designed to meet their needs. Alerus operates 25 banking and commercial wealth offices, with locations in Grand Forks and Fargo, North Dakota; the Minneapolis-St. Paul, Minnesota metropolitan area; Rochester, Minnesota; Southern Minnesota; Marshalltown, Iowa; Pewaukee, Wisconsin; and Tempe and Scottsdale, Arizona. The Alerus Retirement and Benefit business serves advisors, brokers, employers, and plan participants across the United States.

Al Villalon, Chief Financial Officer
952-417-3733 (Office)
[email protected]
Investors.Alerus.com


Risks

  • Market conditions or financial performance may lead to fluctuations in the reported Q3 results, impacting investor sentiment.
  • Competition in the banking and retirement services sectors can influence future growth and profitability.
  • Economic factors affecting consumer and business clients, such as interest rates or employment levels, could present operational risks.

More from Press Releases

Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A) Oct 2, 2026 Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 Oct 1, 2026 New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program Oct 1, 2026 FEMSA Schedules Conference Call to Discuss Third Quarter Financial Results Oct 1, 2026 Exodus Brings Stablecoins to Everyday Commerce, Starting With DIRECTV’s DGO Oct 1, 2026